Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

F. Vogl · SciRah

Researcher profile · Semantic Scholar

F. Vogl

Share profile

F. Vogl — researcher profile on SciRah

h-index: 19
Works: 53
Citations: 2,788

Most-cited papers

A pooled analysis of bone marrow micrometastasis in breast cancer.
S. Braun, F. Vogl, B. Naume, W. Janni +18 more
2005New England Journal of Medicine1,371 citations Open access
Semantic Scholar
Persistence of Disseminated Tumor Cells in the Bone Marrow of Breast Cancer Patients Predicts Increased Risk for Relapse—A European Pooled Analysis
W. Janni, F. Vogl, G. Wiedswang, Marit Synnestvedt +11 more
2011Clinical Cancer Research242 citations Open access
Semantic Scholar
Increased risk for nonmedullary thyroid cancer in the first degree relatives of prevalent cases of nonmedullary thyroid cancer: a hospital-based study.
T. Pal, F. Vogl, P. Chappuis, R. Tsang +8 more
2001Journal of Clinical Endocrinology and Metabolism161 citations
Semantic Scholar
Glutathione S-transferases M1, T1, and P1 and breast cancer: a pooled analysis.
F. Vogl, E. Taioli, C. Maugard, Wei Zheng +7 more
2004Cancer Epidemiology, Biomarkers and Prevention118 citations
Semantic Scholar
Final results of a phase 3 study of trebananib plus weekly paclitaxel in recurrent ovarian cancer (TRINOVA-1): Long-term survival, impact of ascites, and progression-free survival-2.
B. Monk, A. Poveda, I. Vergote, F. Raspagliesi +19 more
2016Gynecologic Oncology90 citations Open access
Semantic Scholar
A Phase II Randomized Study of Neoadjuvant Letrozole Plus Alpelisib for Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Breast Cancer (NEO-ORB)
I. Mayer, A. Prat, D. Egle, S. Blau +19 more
2019Clinical Cancer Research87 citations Open access
Semantic Scholar
Sentinel-node biopsy for axillary staging in breast cancer: results from a large prospective German multi-institutional trial.
T. Kuehn, F. Vogl, Gisela Helms, S. V. Pückler +4 more
2004European Journal of Surgical Oncology86 citations
Semantic Scholar
The genetic study of three population microisolates in South Tyrol (MICROS): study design and epidemiological perspectives
C. Pattaro, F. Marroni, A. Riegler, D. Mascalzoni +15 more
2007BMC Medical Genetics80 citations Open access
Semantic Scholar
ENGOT-ov-6/TRINOVA-2: Randomised, double-blind, phase 3 study of pegylated liposomal doxorubicin plus trebananib or placebo in women with recurrent partially platinum-sensitive or resistant ovarian cancer.
C. Marth, I. Vergote, G. Scambia, W. Oberaigner +20 more
2017European Journal of Cancer72 citations Open access
Semantic Scholar
Sentinel-Node-Biopsie beim Mammakarzinom - Ergebnisse einer prospektiven Multizenterstudie
T. Kühn, F. Vogl, C. Santjohanser, J. Kotzerke +4 more
200172 citations
Semantic Scholar
Restless legs syndrome: Epidemiological and clinicogenetic study in a South Tyrolean population isolate
F. Vogl, I. Pichler, Susanna Adel, G. K. Pinggera +9 more
2006Movement Disorders41 citations
Semantic Scholar
A phase 1, first-in-human study of AMG 900, an orally administered pan-Aurora kinase inhibitor, in adult patients with advanced solid tumors
M. Carducci, M. Shaheen, B. Markman, S. Hurvitz +10 more
2018Investigational new drugs40 citations Open access
Semantic Scholar
A Phase I Study of the Pan-Notch Inhibitor CB-103 for Patients with Advanced Adenoid Cystic Carcinoma and Other Tumors
G. Hanna, A. Stathis, E. Lopez-Miranda, F. Racca +22 more
2023Cancer Research Communications37 citations Open access
Semantic Scholar
Hospitalizations, outcomes, and management costs of febrile neutropenia in patients from a managed care population
A. Kawatkar, A. Farias, C. Chao, Wansu Chen +3 more
2017Supportive Care in Cancer37 citations Open access
Semantic Scholar
A phase 1 study of AMG 900, an orally administered pan-aurora kinase inhibitor, in adult patients with acute myeloid leukemia
H. Kantarjian, M. Schuster, N. Jain, A. Advani +9 more
2017American journal of hematology/oncology33 citations Open access
Semantic Scholar
Prospective Evaluation of Factors Influencing Success Rates of Sentinel Node Biopsy in 814 Breast Cancer Patients
H. Schirrmeister, J. Kotzerke, F. Vogl, A. Buck +5 more
2004Cancer Biotherapy and Radiopharmaceuticals28 citations
Semantic Scholar
p53 autoantibodies can be indicative of the development of breast cancer relapse.
S. Regele, F. Vogl, T. Köhler, R. Kreienberg +1 more
2003Anticancer Research22 citations
Semantic Scholar
Evaluation of bone marrow in breast cancer patients: prediction of clinical outcome and response to therapy.
S. Braun, F. Vogl, W. Janni, C. Marth +2 more
2003Breast22 citations Open access
Semantic Scholar
Phase 1 study of CB-103, a novel first-in-class inhibitor of the CSL-NICD gene transcription factor complex in human cancers.
E. Lopez-Miranda, A. Stathis, D. Hess, F. Racca +16 more
202120 citations
Semantic Scholar
Population Isolates in South Tyrol and Their Value for Genetic Dissection of Complex Diseases
F. Marroni, I. Pichler, A. De Grandi, C. Volpato +4 more
2006Annals of Human Genetics18 citations
Semantic Scholar
CB‐103: A novel CSL‐NICD inhibitor for the treatment of NOTCH‐driven T‐cell acute lymphoblastic leukemia: A case report of complete clinical response in a patient with relapsed and refractory T‐ALL
M. Medinger, Till Junker, D. Heim, A. Tzankov +7 more
2022eJHaem16 citations Open access
Semantic Scholar
Clinical activity of vofatamab (V), an FGFR3 selective antibody in combination with pembrolizumab (P) in metastatic urothelial carcinoma (mUC), updated interim analysis of FIERCE-22
A. Siefker-Radtke, I. Lugowska, K. Tupikowski, Z. Andrić +7 more
2019Annals of Oncology13 citations Open access
Semantic Scholar
Impact of trebananib plus weekly paclitaxel on overall survival (OS) in patients (pts) with recurrent ovarian cancer and ascites: Results from the phase III TRINOVA-1 study.
B. Monk, A. Poveda, I. Vergote, F. Raspagliesi +15 more
201513 citations
Semantic Scholar
The use of granulocyte colony stimulating factor (G-CSF) and management of chemotherapy delivery during adjuvant treatment for early-stage breast cancer--further observations from the IMPACT solid study.
J. Mäenpää, I. Varthalitis, F. Erdkamp, A. Trojan +5 more
2016Breast9 citations Open access
Semantic Scholar
Chemotherapy treatment patterns and neutropenia management in gastric cancer
E. Kalinka-Warzocha, J. G. Plazas, L. Mineur, T. Šálek +4 more
2015Gastric Cancer9 citations Open access
Semantic Scholar
Interim analysis of the fierce-21 phase 2 (P2) study of vofatamab (B-701), a selective inhibitor of FGFR3, as salvage therapy in metastatic urothelial carcinoma (mUC).
B. Mellado, D. Castellano, S. Pang, Y. Urun +7 more
2019Journal of Clinical Oncology8 citations
Semantic Scholar
Health-related quality of life in women with recurrent ovarian cancer receiving paclitaxel plus trebananib or placebo (TRINOVA-1).
K. Fujiwara, B. Monk, C. Lhommé, R. Coleman +12 more
2016Annals of Oncology7 citations Open access
Semantic Scholar
Occult Pathologic Findings in Reduction Mammaplasty in 5781 Patients—An International Multicenter Study
B. Kuehlmann, F. Vogl, T. Kempný, G. Djedovic +17 more
2020Journal of Clinical Medicine6 citations Open access
Semantic Scholar
Disseminated tumor cells: are they ready for clinical use?
S. Braun, F. Vogl, Alois Schneitter, D. Egle +3 more
2007Breast6 citations
Semantic Scholar
Risks of cancer due to a single BRCA1 mutation in an extended Utah kindred
F. Vogl, M. Badzioch, L. Steele, S. Neuhausen +1 more
2006Familial Cancer5 citations
Semantic Scholar
Adapted Finnish Migraine‐Specific Questionnaire for family studies (FMSQFS): a validation study in two languages
Maurizio F. Facheris, F. Vogl, S. Hollmann, G. Sixt +3 more
2008European Journal of Neurology4 citations
Semantic Scholar
Disseminated tumor cells (DTC) in bone marrow (BM) and clinical outcome: Final results of pooled analysis on 10-year survival of 4,703 breast cancer patients
S. Braun, F. Vogl, K. Pantel
20053 citations
Semantic Scholar
Gene expression patterns in adenoid cystic carcinoma with and without diffuse NOTCH1 intracellular domain (NICD1) immunohistochemistry staining.
Karan Patel, Massimiliano Manzo, B. Hapuarachi, S. Rack +11 more
2023Oral Oncology2 citations
Semantic Scholar
Abstract 3008: Preclinical characterization of AMG 900, a pan-aurora kinase inhibitor, alone and in combination with taxanes in ovarian cancer
O. Kalous, D. Conklin, Kanthinh Manivong, W. Wayne +11 more
20162 citations
Semantic Scholar
Phase 1 Study of AMG 900, an Orally Administered Pan-Aurora Kinase Inhibitor, in Adult Patients (Pts) with Acute Myeloid Leukemia (AML)
M. Schuster, M. Sekeres, E. Gamelin, E. Rasmussen +6 more
20152 citations Open access
Semantic Scholar
Prognostic value of bone marrow micrometastasis on disease outcome in 4703 breast cancer patients: meta- and pooled analysis after 10 years of follow-up
F. Vogl, K. Pantel
20062 citations
Semantic Scholar
Sentinel node biopsy in breast cancer - technical performance is more important than patient selection to avoid false-negative findings
T. Kuehn, F. Vogl, S. V. Pückler, G. Helms +5 more
20012 citations
Semantic Scholar
562P Target engagement and clinical safety of CB-103, a first-in-class small molecule inhibitor of the NOTCH transcription complex
A. B. Azaro Pedrazzoli, J. Pérez-García, J. Cortés, E. Miranda +16 more
20201 citations Open access
Semantic Scholar
Abstract P5-21-06: Alpelisib plus letrozole in estrogen receptor-Positive (ER+), human epidermal growth factor receptor 2-negative (HER2–) advanced breast cancer (aBC): Safety and preliminary efficacy analysis from a phase 1b trial
D. Juric, A. Gonçalves, E. Hamilton, V. Boni +6 more
20181 citations
Semantic Scholar
Abstract CT045: Phase 1, open-label, first-in-human study of AMG 900, an orally administered pan-aurora kinase inhibitor, in adult patients (pts) with advanced solid tumors
M. Shaheen, B. Markman, M. Carducci, S. Hurvitz +10 more
20161 citations
Semantic Scholar
Abstract 439: Detection of aurora kinase A (AURKA) focal amplification in plasma samples of patients with recurrent ovarian cancer
Gloria Juan, K. Paweletz, A. Anderson, E. Gamelin +3 more
20161 citations
Semantic Scholar
Risk Factors For Bone Pain Among Patients Receiving Myelosuppressive Chemotherapy and Primary Prophylactic Pegfilgrastim
Hairong Xu, Q. Gong, F. Vogl, E. Abella +1 more
20131 citations
Semantic Scholar
Presence of bone marrow micrometastasis (BMM) in breast cancer patients predicts a poor-prognosis pattern of first distant metastasis: Results from the pooled analysis.
S. Braun, F. Vogl, K. Pantel
2006Journal of Clinical Oncology1 citations
Semantic Scholar
978P Clinical activity of TT125-802, a highly selective bromodomain inhibitor of CBP/p300, in advanced solid tumors: Update on the ongoing phase I study
O. Saavedra, E. Garralda, V. Boni, J. F. Antrás +10 more
2025Annals of Oncology0 citations Open access
Semantic Scholar
Clinical activity of vofatamab, an FGFR3 selective antibody in combination with pembrolizumab in metastatic urothelial carcinoma (mUC), updated follow up results from the interim analysis of FIERCE-22
A. Siefker-Radtke, I. Lugowska, K. Tupikowski, Z. Andrić +7 more
2019European urology. Supplement0 citations
Semantic Scholar
Population pharmacokinetics (pop PK) and exposure-safety analysis to reveal patient factors that affect AMG 900 tolerability.
V. Chow, Joanna Z. Peng, F. Vogl, J. Gibbs
20160 citations
Semantic Scholar
Febrile neutropenia and mortality in patients with breast cancer, lung cancer, and non-Hodgkin lymphoma.
A. Kawatkar, C. Chao, Wansu Chen, R. Barron +4 more
20140 citations
Semantic Scholar
Chemotherapy (CT) treatment patterns and neutropenia management in gastric cancer patients (pts) receiving myelosuppressive chemotherapy in Europe.
E. Kalinka-Warzocha, J. G. Plazas, L. Mineur, T. Šálek +4 more
20130 citations
Semantic Scholar
RASSF1A DNA methylation in bone marrow (mRASSF1ABM) or peripheral blood plasma (mRASSF1APB) of primary breast cancer (BC) patients
S. Braun, D. Auer, F. Vogl, Alois Schneitter +5 more
20070 citations
Semantic Scholar
Evaluation of bone marrow: Prediction of outcome and response
S. Braun, F. Vogl, W. Janni, C. Marth +2 more
20030 citations Open access
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

S. Braun×8
Invite
S. Braun — researcher profile on SciRah
C. Marth×7
Invite
C. Marth — researcher profile on SciRah
K. Pantel×6
Invite
K. Pantel — researcher profile on SciRah
Gloria Juan×6
Invite
Gloria Juan — researcher profile on SciRah

×6

Invite

G. Friberg — researcher profile on SciRah

Invite

E. Gamelin — researcher profile on SciRah

Invite

V. Chow — researcher profile on SciRah

Invite

R. Lehal — researcher profile on SciRah

Invite

W. Janni — researcher profile on SciRah

Invite

B. Monk — researcher profile on SciRah

Invite

I. Vergote — researcher profile on SciRah

Invite

B. Bach — researcher profile on SciRah